Alnylam pharmaceuticals Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Alnylam pharmaceuticals Contact Number

Contact Alnylam® Pharmaceuticals

5 hours ago Alnylam.com Show details

617.551.8200

ALNYLAM PHARMACEUTICALS, INC – CORPORATE HEADQUARTERS. 675 West Kendall St Cambridge, MA 02142 USA Tel: 617.551.8200 Fax: 617.551.8101

Category: Contact SupportShow more

Alnylam Pharmaceuticals, Inc. Company Profile Cambridge

1 hours ago Dnb.com Show details

(617) 551-8200

Address. 675 W Kendall St. Cambridge , MA , 02142-1168. United States. See other locations. Phone. (617) 551-8200. Company Description. Like a genetic linebacker, Alnylam Pharmaceuticals runs interference with RNA to prevent the forward progress of disease.

Employees: 1.5K
Cash and Cash Equivalents: $547.18
Accounts Receivable: $43.01
Location: 675 W Kendall St, Cambridge, 02142-1168, MA

Category: Contact NumberShow more

Contact Alnylam Policies

5 hours ago Alnylampolicies.com Show details

647-499-1053

ALNYLAM CANADA ULC. 4 Robert Speck Parkway Suite 1522 Mississauga, Ontario L4Z 1S1 Canada Tel: 1-647-499-1053 Toll-Free: 1-833-673-6119 View Map ›

Category: Contact SupportShow more

Alnylam® Pharmaceuticals

4 hours ago Alnylam.com Show details

Alnylam Is the Leading RNAi Therapeutics Company. Alnylam has led the translation of RNAi (RNA interference) from Nobel Prize-winning discovery into an entirely new class of medicines. In 2018, our first medicine, ONPATTRO® (patisiran), became the world’s first approved RNAi therapeutic. Our second medicine, GIVLAARI® (givosiran), was

Category: Contact NumberShow more

Alnylam Pharmaceuticals it Contacts Business Emails, Phone

6 hours ago Adapt.io Show details

Find the Alnylam Pharmaceuticals company's it team/department contact details such as business emails, phone numbers, web address and other details. Get access to 100M+ contacts on Adapt.io.

Category: Phone Number, Contact SupportShow more

Contact Alnylam® Pharmaceuticals Canada

3 hours ago Alnylam.ca Show details

905-361-9847

ALNYLAM CANADA ULC. 4 Robert Speck Parkway Suite 1522 Mississauga, Ontario L4Z 1S1. [email protected]alnylam.ca. Tel: Toll: 1-905-361-9847 Toll-free: 1-833-673-6119 Fax: Toll: 1-613-701-4273 Toll-free: 1-833-673-6122 For medical information or to report an adverse event or product complaint:

Category: Contact SupportShow more

Alnylam Assist® Patient Support

Just Now Alnylamassist.com Show details

833-256-2748

tell us who you are. I am learning. I am a patient. I am a caregiver. I am a Healthcare Professional. If you have questions before you get started, you can get more information about Alnylam Assist® below, or call us at: 1-833-256-2748. Monday - Friday, 8am - 6pm ET.

Category: Support NumberShow more

Employment Verification for Alnylam Pharmaceuticals Truework

7 hours ago Truework.com Show details

803-859-4696

The information on this page is not an endorsement of Truework's services by Alnylam Pharmaceuticals and is meant to be purely informational. number of employees. 1001-5K. category Pharmaceuticals. address 300 Third St, Cambridge, MA 02142, USA. links Alnylam Pharmaceuticals Website. Contact us. 1-803-859-4696

Category: Contact NumberShow more

Alnylam Pharmaceuticals Company Profile Office Locations

Just Now Craft.co Show details

Alnylam Pharmaceuticals has 1,323 employees across 7 locations and $492.85 M in annual revenue in FY 2020. See insights on Alnylam Pharmaceuticals including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.

Category: Contact NumberShow more

Kelly Bierly Alnylam Pharmaceuticals MA USA Database

Just Now Bestdataprovider.com Show details

Kelly Bierly is serving as Vice President, Legal in the Alnylam Pharmaceuticals is an active company headquartered in Cambridge, MA in the states of MA.The Alnylam Pharmaceuticals office address is located at 300 Third St, Cambridge, MA, 02142, United States.The company comes under Biotech/Healthcare->BioTech/Drugs industries.

Category: Contact NumberShow more

GIVLAARI® (givosiran) Alnylam Connect

5 hours ago Alnylamconnect.com Show details

Healthcare professionals only: Learn more about GIVLAARI by speaking with an Alnylam representative (by phone, email, video chat, or in person); fill out the contact form …

Category: Contact NumberShow more

Alnylam Netherlands Alnylam Alnylam Pharmaceuticals

4 hours ago Alnylam.com Show details

800 403 0002

Cross Towers, 20 e verdieping. Antonio Vivaldistraat 150. 1083 HP Amsterdam. Nederland. [email protected]alnylam.nl. 0800 403 0002 / 020 3697850. Voor medische informatie, vragen over klinische studies, bijwerkingen en productklachten: Email: [email protected]alnylam.com. Telefoon: 0800 …

Category: Contact NumberShow more

The Alnylam® Leadership Team Alnylam® Pharmaceuticals

7 hours ago Alnylam.com Show details

John Maraganore, P h D Chief Executive Officer. Since 2002, Dr. John Maraganore has served as the CEO and a Director of Alnylam. Prior to Alnylam, Dr. Maraganore served as an officer and a member of the management team for Millennium Pharmaceuticals, Inc.

Category: Contact NumberShow more

Our Approved Products Alnylam® Pharmaceuticals

7 hours ago Alnylam.com Show details

The following content may not be associated with Alnylam Pharmaceuticals. Links to all outside sites are provided as a reference for our visitors. Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by …

Category: Contact NumberShow more

Alnylam Assist® Contact the Team ONPATTRO® (patisiran)

5 hours ago Alnylamassist.com Show details

833-256-2748

Alnylam Assist® Contact the Team ONPATTRO® (patisiran) 1-833-256-2748.

Category: Contact SupportShow more

Rajesh Patel's email & phone number Senior Scientist

7 hours ago Signalhire.com Show details

View Rajesh Patel's email address: [email protected]alnylam.com & phone: +1-xxx-xxx-0120's profile as Senior Scientist, Quality Control at Alnylam Pharmaceuticals, located in Greater Boston. Find contacts: direct phone number, email address, work experience.

Category: Phone NumberShow more

Alnylam Assist® Contact the Team OXLUMO™ (lumasiran)

3 hours ago Alnylamassist.com Show details

Alnylam Assist® is committed to the patient experience of those who start treatment with OXLUMO TM (lumasiran). Each patient is partnered with a dedicated Case Manager who can provide support and assistance throughout treatment: • Insurance benefit verification and connecting with a Field Reimbursement Director.

Category: Contact SupportShow more

Alnylam Pharmaceuticals Press Release Apr 11, 2021

2 hours ago Investors.alnylam.com Show details

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr. 11, 2021-- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today positive interim results from the ongoing Phase 1 study of ALN-AGT, a subcutaneous investigational RNAi therapeutic targeting liver-expressed angiotensinogen (AGT) for the treatment of hypertension.

Category: Contact NumberShow more

Therapeutic Areas Alnylam Connect

Just Now Alnylamconnect.com Show details

Healthcare professionals only: Learn more about Alnylam's therapeutic areas by speaking with an Alnylam representative (by phone, email, video chat, or in person); fill out the contact form here and a representative will reach out to you.

Category: Contact NumberShow more

Financial Information Alnylam Pharmaceuticals, Inc.

1 hours ago Investors.alnylam.com Show details

If you’re having trouble finding something specific please send an inquiry to [email protected]alnylam.com. Sep 08, 2021. Form 8-K. Report of unscheduled material events or corporate event. rtf xls pdf. Aug 16, 2021. 3,4,5. Statement of changes in …

Category: Contact NumberShow more

Start Connecting With an Alnylam Educator The Bridge®

6 hours ago Hattrbridge.com Show details

*Please enter your phone number. OK to leave voicemail. I would like a Patient Education Liaison to contact me with information about hATTR amyloidosis. Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.

Category: Contact NumberShow more

Alnylam Pharmaceuticals: Number of Employees 20062021

Just Now Macrotrends.net Show details

Number of Employees. Interactive chart of Alnylam Pharmaceuticals (ALNY) annual worldwide employee count from 2006 to 2021. Alnylam Pharmaceuticals total number of employees in 2020 was 1,453, a 9.83% increase from 2019. Alnylam Pharmaceuticals total number of employees in 2019 was 1,323, a 24.23% increase from 2018.

Category: Contact NumberShow more

Alnylam Pharmaceuticals Press Release Mar 11, 2021

2 hours ago Investors.alnylam.com Show details

Alnylam Issues Inaugural Corporate Responsibility Summary. Mar 11, 2021 – New Strategic Framework Highlights Alnylam’s Approach to Corporate Responsibility, Establishing the Foundation for Continuous Tracking of Initiatives and Progress — CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar. 11, 2021-- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi …

Category: Contact NumberShow more

Cara Hesse Director, Patient Advocacy & Engagement

4 hours ago Open.winmo.com Show details

Verified contact information for Cara Hesse - Director, Patient Advocacy & Engagement - Lumasiran, Alnylam Pharmaceuticals including email address, phone number and personality insights that will make your sales and marketing efforts much more effective.

Email: c*****@*******.com
Location: 675 West Kendall Street, Cambridge, 02142, MA

Category: Contact NumberShow more

Alnylam Pharmaceuticals Press Release Jun 30, 2021

2 hours ago Investors.alnylam.com Show details

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun. 30, 2021-- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced initiation of KARDIA-1, a global Phase 2 study evaluating the efficacy and safety of zilebesiran (pronounced “zile-BEE-siran” and formerly known as ALN-AGT), an investigational subcutaneous

Category: Contact NumberShow more

Nitin Mehrotra's email & phone number Senior Director

Just Now Signalhire.com Show details

View Nitin Mehrotra's email address: [email protected]alnylam.com & phone: +1-xxx-xxx-2710's profile as Senior Director, Head of Pharmacometrics at Alnylam Pharmaceuticals, located in Cambridge, Massachusetts. Find contacts: direct phone number, email address, work experience.

Category: Phone NumberShow more

Privacy Policy Alnylam Policies

5 hours ago Alnylampolicies.com Show details

844.543.8355

If you wish to contact us to receive further information regarding our use of your personal data, or if you wish to access your personal data, please complete this Data Subject Request form, email us at [email protected]alnylam.com, or call us at 844.543.8355 or as specified in …

Category: Contact NumberShow more

Barry Greenstein Senior Manager, Global Digital

5 hours ago Winmo.com Show details

Verified contact information for Barry Greenstein - Senior Manager, Global Digital Marketing, Alnylam Pharmaceuticals including email address, phone number and personality insights that will make your sales and marketing efforts much more effective.

Category: Contact NumberShow more

Alnylam Inaugurates New Biotech Facility in the

3 hours ago Investinholland.com Show details

The Netherlands remained Alnylam’s top choice for establishing its new, state-of-the-art biotech facility for a number of reasons. For starters, the Amsterdam area and the country at-large offer top talent, infrastructure, an R&D ecosystem and world-class academic hospitals within the Dutch life sciences and health sector.

Category: Tech SupportShow more

Alnylam Pharmaceuticals Press Release Dec 07, 2020

2 hours ago Investors.alnylam.com Show details

Alnylam Issues 2nd Annual Patient Access Philosophy Report Highlighting Broad Access to the Company’s Approved Therapies. Dec 07, 2020. − Company Also Introduces Inaugural ‘Rare Disease Trend Report’ Providing Insights Gleaned Through Interviews and Research with Payers − . CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec. 7, 2020-- Alnylam Pharmaceuticals, Inc. (Nasdaq: …

Category: Contact NumberShow more

Alnylam Pharmaceuticals, Inc., Jobs & Salary for Foreign

3 hours ago Myvisajobs.com Show details

Alnylam Pharmaceuticals, Inc. has filed 34 labor condition applications for H1B visa and 13 labor certifications for green card from fiscal year 2018 to 2020. Alnylam Pharmaceuticals was ranked 5572 among all visa sponsors. Please note that 3 LCA for H1B Visa and 0 LC for green card have been denied or withdrawn during the same period.

Category: Contact NumberShow more

Alnylam's Response to COVID19 Alnylam® Newsroom

4 hours ago News.alnylam.com Show details

31 20 369

Outside of the U.S., please email us at [email protected]alnylam.com or from within Europe, call +31 20 369 7861, from Canada, call 877.356.9526, from Japan, call 03-4520-8966 and from Brazil, call 0800-0474597. Healthcare providers and patients who need assistance with Alnylam Act, our 3 rd party genetic testing and counseling program available in the

Category: Contact NumberShow more

Alnylam Named to Bloomberg's 2021 GenderEquality Index

1 hours ago News.alnylam.com Show details

Alnylam Pharmaceuticals. We're thrilled and honored to have been selected to Bloomberg's Gender-Equality Index (GEI) for 2021. The GEI is published annually by the business-focused media company as a resource for investors and standardizes, measures and contextualizes workplace gender metrics data supplied to Bloomberg voluntarily by companies.

Category: Contact NumberShow more

Alnylam Assist® Electronic Patient Start Form GIVLAARI

Just Now Alnylamassist.com Show details

The purpose of this form is to permit Alnylam Assist® participants to receive information and support (“Patient Support”) from Alnylam Pharmaceuticals, Inc., its affiliates, representatives, agents, and contractors (“Alnylam”). Alnylam Assist® provides Patient Support to eligible patients who have been prescribed an Alnylam medicine.

Category: Contact NumberShow more

Alnylam's (ALNY) Q2 Earnings Miss Estimates, 2021 Guidance Up

6 hours ago Finance.yahoo.com Show details

Alnylam Pharmaceuticals, Inc. ALNY incurred a loss of $1.61 per share in the second quarter of 2021, wider than the Zacks Consensus Estimate of a …

Category: Contact NumberShow more

Alnylam Pharmaceuticals Funding, Financials, Valuation

2 hours ago Crunchbase.com Show details

Alnylam Pharmaceuticals has raised a total of $2.5B in funding over 6 rounds. Their latest funding was raised on Apr 13, 2020 from a Post-IPO Debt round. Alnylam Pharmaceuticals is registered under the ticker NASDAQ:ALNY . Their stock opened with $6.00 in its Jun 4, 2004 IPO. Alnylam Pharmaceuticals is funded by 11 investors.

Category: Contact NumberShow more

Top Alnylam Pharmaceuticals Competitors and Alternatives

2 hours ago Craft.co Show details

Alnylam Pharmaceuticals's main competitors include Reata Pharmaceuticals, Celyad, Sorrento Therapeutics, Moderna, CureVac, Regulus Therapeutics, Sarepta Therapeutics and Ionis Pharmaceuticals. Compare Alnylam Pharmaceuticals to its competitors by revenue, employee growth and other metrics at Craft.

Category: Contact NumberShow more

Joe Kubiak Facilities Manager Alnylam Pharmaceuticals

6 hours ago Linkedin.com Show details

Alnylam's Manufacturing group in Norton has a number of open positions for various experience levels. Whether you're a new graduate or you've been in… Liked by Joe Kubiak

Title: Facilities Manager at Alnylam
Location: Suffolk County, Massachusetts, United States
1. 500+ connections

Category: Contact NumberShow more

$ALNY: Investors will love the forecast for Alnylam

1 hours ago Wallstreetfacts.com Show details

The 52-week high for Alnylam Pharmaceuticals, Inc. is $212 and the low is $119.29. We will be moving onto the number of outstanding shares. One is that you can use shares outstanding to calculate the market capitalization, the total value, of a corporation.

Category: Contact NumberShow more

Where Alnylam Pharmaceuticals Stands With Analysts

9 hours ago Markets.businessinsider.com Show details

These 8 analysts have an average price target of $219.75 versus the current price of Alnylam Pharmaceuticals at 204.27, implying upside. Below is …

Category: Contact NumberShow more

Alnylam Named a Fast Company World's Most Innovative

7 hours ago News.alnylam.com Show details

Alnylam Pharmaceuticals Alnylam has been named a Fast Company World's 50 Most Innovative Company for 2019, number 3 in the Biotech category and number 32 overall. We are incredibly honored to have been recognized by Fast Company for our innovation in developing RNAi (RNA interference) therapeutics as a new class of medicines.

Category: Contact NumberShow more

Isis and Alnylam Launch Regulus Therapeutics, a Joint

Just Now Ir.ionispharma.com Show details

617-551-8207

SOURCE: Alnylam Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. Cynthia Clayton (Investors), 617-551-8207 or KMorrisPR Kathryn Morris (Media), 845-635-9828 or Isis Pharmaceuticals, Inc. Kristina Lemonidis, 760-603-2490 Associate Director, Investor Relations or Amy Blackley, Ph.D., 760-603-2772 Manager, Corporate Communications

Category: Contact NumberShow more

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Price & News

8 hours ago Google.com Show details

Get the latest Alnylam Pharmaceuticals, Inc. (ALNY) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Category: Contact NumberShow more

Alnylam Named a Best Workplace in Switzerland & UK

3 hours ago News.alnylam.com Show details

Alnylam Pharmaceuticals. Alnylam's offices in Zug, Switzerland and Maidenhead, UK (a suburb of London) were both recently named to Great Place to Work's Best Workplaces for 2019. These achievements highlight the dynamic and engaging work cultures that exist across Alnylam's global network of offices. Alnylamn Switzerland was named number 4 in

Category: Contact NumberShow more

Sustainable Alnylam Pharmaceuticals's ESG performance data

1 hours ago Sustainable.com Show details

Alnylam Pharmaceuticals. Alnylam Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in developing novel therapeutics based on RNA interference, or RNAi. RNAi is a naturally occurring biological pathway within cells for regulating the expression of specific genes.

Category: Contact NumberShow more

$ALNY: Investors will love the forecast for Alnylam

1 hours ago Wallstreetfacts.com Show details

The 52-week high for Alnylam Pharmaceuticals, Inc. is $209.73 and the low is $119.29. We will be moving onto the number of outstanding shares. One is that you can use shares outstanding to calculate the market capitalization, the total value, of a corporation.

Category: Contact NumberShow more

Alnylam Pharmaceuticals, Inc. (ALNY) Fell Out Of Favor

3 hours ago Finance.yahoo.com Show details

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) shares haven't seen a lot of action during the second quarter. Overall, hedge fund sentiment was unchanged. The stock was in 33 hedge funds' portfolios

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

What kind of company is alnylam pharmaceuticals inc?

Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.

How to contact alnylam for its clinical trials?

For questions regarding our clinical trials, in the US, please call 877.ALNYLAM (877.256.9526) and in the EU, please call +31 20 369 7861 or email us at [email protected]

How is the stock price of alnylam determined?

A valuation method that multiplies the price of a company's stock by the total number of outstanding shares. Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases.

Who is the chief operating officer of alnylam?

He is a member of the Board for Agios Pharmaceuticals and Biotechnology Industry Organization (BIO) Board and is a member of the BIO Executive Committee. Dr. Yvonne Greenstreet joined Alnylam in 2016 as Chief Operating Officer and was promoted to President and COO in 2020.

Brand New Updated

Popular Brands

Amazon
Abbvie
Aia
Asml
Apple
Att
Amgen
Adobe
Aptar
Acc
Adidas
Aak
Aes
Asx